Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Ocumension Therapeutics
  6. News
  7. Press Releases
    1477   KYG674111011

OCUMENSION THERAPEUTICS

(1477)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société OCUMENSION THERAPEUTICS
2021OCUMENSION THERAPEUTICS : Acquires all the Equity Interests in Two Ophthalmic Products Mai..
PR
2021OCUMENSION THERAPEUTICS : Announces 2021 Interim Results
PR
2021OCUMENSION THERAPEUTICS : Notice of extraordinary general meeting
PU
2021OPKO Health to Develop and Commercialize RAYALDEE in Greater China with Nicoya Therapeu..
AQ
2021OCUMENSION THERAPEUTICS : Voluntary announcement ind application received for a phase iii ..
PU
2021OCUMENSION THERAPEUTICS : Completion of the transactions under share purchase agreement
PU
2021OCUMENSION THERAPEUTICS : Voluntary announcement approval for commencement of initial pedi..
PU
2021OCUMENSION THERAPEUTICS : (i) discloseable transactions relating to the exclusive license ..
PU
2021OCUMENSION THERAPEUTICS : Voluntary announcement first patient enrolled in the phase iii c..
PU
2021OCUMENSION THERAPEUTICS : Voluntary announcement new drug application for ot-401 accepted ..
PU
2021OCUMENSION THERAPEUTICS : Change of non-executive director
PU
2021OCUMENSION THERAPEUTICS : Voluntary announcement inclusion of the shares of the company in..
PU
2021OCUMENSION THERAPEUTICS : Voluntary announcement second phase iii clinical trial of ot-301..
PU
2021OCUMENSION THERAPEUTICS : Voluntary announcement selection of the shares of the company as..
PU
2020OCUMENSION THERAPEUTICS : Voluntary announcement phase iii clinical trial of ot-1001 (zerv..
PU
2020OCUMENSION THERAPEUTICS : Announcement acquisition of 100% equity interest in suzhou xiaxi..
PU
2020OCUMENSION THERAPEUTICS : Interim results announcement for the six months ended june 30, 2..
PU